Listing Title
Listing Category
Description
A phase 3b/4 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Verify the Clinical Benefit of Aducanumab (BIIB037) in Participants with Alzheimer’s Disease.
Study Status
Active: Open to Patient Enrollment
Trial Documentation:
Principal Investigator
Dr. Monica Crane, Genesis Neuroscience Clinic
Listing Title
Listing Category
Description
A Phase 3 Double-blind, Randomized, Placebo-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of AR1001 over 52 Weeks in Participants with Early Alzheimer’s Disease.
Study Status
Active: Open to Patient Enrollment
Trial Documentation:
Principal Investigator
Dr. Monica Crane, Genesis Neuroscience Clinic
Listing Title
Listing Category
Description
Alzheimer’s Network for Treatment and Diagnostics. Observational study for patients who are being treated with Novel FDA approved therapies.
Study Status
Active: Open to Patient Enrollment
Trial Documentation:
Principal Investigator
Dr. Monica Crane, Genesis Neuroscience Clinic